Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-05-03

Clinical Trial Update: Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating granulocyte colony-stimulating factor with N-acetylcysteine in severe alcoholic hepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Alcoholic Hepatitis | Phase 4 | Status: COMPLETED